An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration

Brain Research Reviews

Volumn 29, Issue 1, 1999, Pages 1-25

  Cassarino, David S ^a   Bennett Jr , James P ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

ALS; Alzheimer's disease; Apoptosis; Cyclosporin A; Mitochondria; Mitochondrial mutation; Mitochondrial permeability transition pore; Oxidative stress; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; CYTOCHROME C; GLUTATHIONE REDUCTASE; MELATONIN; MITOCHONDRIAL DNA; NITRIC OXIDE SYNTHASE; PRAMIPEXOLE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SELEGILINE; SELENIUM; SUPEROXIDE DISMUTASE; UBIDECARENONE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN MITOCHONDRION; CHANNEL GATING; DEGENERATIVE DISEASE; DRUG TARGETING; ELECTRON TRANSPORT; GENE MUTATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MUTAGENESIS; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; REVIEW; TREATMENT PLANNING;

ANIMALS; CELL DEATH; CELL NUCLEUS; HUMANS; MITOCHONDRIA; MUTATION; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 0032904412     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(98)00046-0     Document Type: Review

References (276)

1. + induced oxygen radical formation with mitochondrial enzymes, Free Rad. Bio. and Med. 15 (1993) 181-186.
2. H.I. Aguilar, R. Botla, A.S. Arora, S.F. Bronk, G.J. Gores, Induction of the mitochondrial permeability transition by protease activity in rats: a mechanism of hepatocyte necrosis, Gastroenterology 110 (1996) 558-566.
3. S.F. Ali, S.N. David, G.D. Newport, J.L. Cadet, W. Slinker Jr., MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine loss, Synapse 18 (1994) 27-34.
4. 2+-induced permeabilization of rat liver mitochondria, Biochem. J. 239 (1986) 19-29.
5. L.M. Ambani, M.H. Van Woert, S. Murphy, Brain peroxidase and catalase in Parkinson's disease, Arch. Neurol. 32 (1975) 114-118.
6. P.M. Andersen, P. Nilsson, V. Ala-Hurula, M.-L. Keranen, I. Tarvainen, T. Haltia, L. Nilsson, M. Binzer, L. Forsgren, S.L. Marklund, Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS. J. Neurol. Sci. 126, 77-83.
7. L. Balazs, M. Leon, Evidence of an oxidative challenge in the Alzheimer's brain, Neurochem. Res. 19 (1995) 1131-1137.
8. B. Bandy, A.J. Davison, Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?, Free Rad. Bio. and Med. 8 (1990) 523-539.
9. L.R. Barlow-Walden, R.J. Reiter, M. Abe, M. Pablos, A. Menendez-Pelaez, L.D. Chen, B. Poeggler, Melatonin stimulates brain glutathione peroxidase activity, Neurochem. Internatl. 26 (1995) 497-502.
10. M.F. Beal, Aging, energy, and oxidative stress in neurodegenerative diseases, Annals of Neurol. 38 (1995) 357-366.
11. M.F. Beal, B.T. Hyman, W. Koroshetz, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?, Trends Neurosci. 16 (1993) 125-131.
12. M.F. Beal, R.T. Matthews, Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases, Mol. Aspects Med. 18 (1997) S169-S179.
13. J.S. Beckman, Oxidative damage and tyrosine nitration from peroxynitrite, Chem. Res. in Toxicol. 9 (1996) 836-844.
14. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshall, B.A. Freeman, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. USA 170 (1990) 1620-1624.
15. J.S. Beckman, M. Carson, C.D. Smith, W.H. Kuppenol, ALS, SOD, and peroxynitrite, Nature 364 (1993) 584.
16. C. Behl, J.B. Davis, R. Lesley, D. Schubert, Hydrogen peroxide mediates amyloid β protein toxicity, Cell 77 (1994) 817-827.
17. M.C. Bennett, D.M. Diamond, S.L. Stryker, J.K. Parks, W.D. Parker Jr., Cytochrome oxidase inhibition: a novel animal model of Alzheimer's disease, J. Geriatr. Psychiatr. Neurol. 5 (1992) 93-101.
18. G. Benzi, A. Moretti, Are reactive oxygen species involved in Alzheimer's disease?, Neurobiol. of Aging 16 (1995) 661-674.
19. P. Bernardi, The permeability transition pore. Control points of a CsA-sensitive mitochondrial channel involved in cell death, Biochim. Biophys. Acta 1275 (1996) 5-9.
20. P. Bernardi, K.M. Broekemeier, D.R. Pfeiffer, Recent progress on regulation of the permeability transition pore, a cyclosporin A-sensitive pore in the mitochondrial inner membrane, J. Bioenerg. Biomembr. 26 (1994) 509-517.
21. P. Bernardi, V. Petronilli, The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal, J. Bioenerg. Biomembr. 28 (1996) 131-138.
22. G. Beutner, A. Ruck, B. Riede, W. Welte, D. Brdiczka, Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore, FEBS Letts. 396 (1996) 189-195.
23. L.A. Bindoff, M. Birch-Machin, N.B. Cartilidge, W.D. Parker Jr., D.M. Turnbull, Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease, J. Neurol. Sci. 104 (1991) 203-208.
24. D. Bironaite, K. Ollinger, The hepatotoxicity of rhein involves impairment of mitochondrial functions, Chem.-Biol. Interacts. 103 (1997) 35-50.
25. O. Blin, C. Desnuelle, O. Rascol, M. Borg, S.P.H. Peyro, J.P. Azulay, F. Bille, D. Figarella et al., Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy, J. Neurol. Sci. 125 (1994) 95-101.
26. C.L. Borders Jr., I.A. Fridovich, Comparison of cyanide, hydrogen peroxide, and phenylglyoxal on eukaryotic and prokaryotic CuZn-SOD, Arch. Biochem. Biophys. 241 (1985) 472-476.
27. A.C. Bowling, M.F. Beal, Bioenergetic and oxidative stress in neurodegenerative diseases, Life Sciences 56 (1995) 1151-1171.
28. F. Braco, M. Scarpa, A. Rigo, L. Battistin, Determination of superoxide dismutase activity by the polarographic method of catalytic currents in the cerebrospinal fluid of aging brain and neurological degenerative diseases, Proc. Soc. Exp. Biol. Med. 196 (1991) 36-41.
29. D.S. Bredt, S.H. Snyder, Nitric oxide: a physiologic messenger molecule, Ann. Rev. of Biochem. 63 (1994) 175-195.
30. K.M. Broekemeier, D.R. Pfeiffer, Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases, Biochemistry 34 (1995) 16440-16449.
31. R.H. Brown, Mitochondria and Oxidative stress in amyotrophic lateral sclerosis, in: M.F. Beal, N. Howell (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, Wiley-Liss, New York, 1997, pp. 309-318.
32. R.S. Burns, C.C. Chiueh, S.P. Markey, M.H. Ebert, D.M. Jacobowitz, I.J. Kopin, A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Proc. Natl. Acad. Sci. USA 80 (1983) 4546-4550.
33. D.S. Cassarino, C.P. Fall, R.H. Swerdlow, T.S. Smith, E.M. Halvorsen, S.M. Miller, J.K. Parks, W.D. Parker Jr., J.P. Bennett Jr., Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease, Biochim. Biophys. Acta 1362 (1997) 77-86.
34. D.S. Cassarino, C.P. Fall, T.S. Smith, J.P. Bennett Jr., Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion, J. Neurochem. 71 (1998) 295-301.
35. D.S. Cassarino, J.K. Parks, R.H. Swerdlow, W.D. Parker Jr., J.P. Bennett Jr., Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids, Biochem. Biophys. Res. Commun. 248 (1998) 168-173.
36. - opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism, Biochim. Biophys. Acta, in press.
37. I. Ceballos, A. Nicole, P. Briand, G. Grimber, A. Delacourte, S. Flament, J.L. Blouin, M. Thevenin, P. Kamoun, P.M. Sinet, Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Downs syndrome, Free Radical Res. Commun. 12-13 (1991) 581-589.
38. I. Ceballos-Picot, M. Merad-Boudia, A. Nicole, M. Thievenin, G. Hellier, S. Legrain, C. Berr, Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase, Free. Rad. Biol. Med. 20 (1996) 579-587.
39. L. Chen, J.S. Richardsone, J.E. Caldwell, L.C. Ang, Regional brain activity of free radical defenses in autopsy samples from patients with Alzheimer's disease and controls, Internatl. J. Neurosci. 75 (1994) 83-90.
40. B.V. Chernyak, P. Bernardi, The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites, Eur. J. Biochem. 238 (1996) 623-630.
41. 2+-triggered membrane permeability transition in deenergized mitochondria from rat liver, FEBS Lett. 365 (1995) 75-78.
42. +, Free Rad. Bio. Med. 13 (1992) 581-583.
43. M.H. Chung, H. Kasai, S. Nishimura, B.P. Yu, Protection of DNA damage by dietary restriction, Free Rad. Bio. Med. 12 (1992) 523-525.
44. M.R. Ciriolo, K. Fiskin, A. DeMartino, M.T. Corasaniti, G. Nistico, G. Rotilil, Age-related changes in CuZn superoxide dismutase, Se-dependent and -independent glutathione peroxidase and catalase activities in specific areas of rat brain, Mech. Aging Dev. 61 (1991) 287-297.
45. C.A. Colton, D.L. Gilbert, Production of superoxide anions by a CNS macrophage, the microglia, FEBS Lett. 223 (1987) 284-288.
46. C.A. Colton, F. Pagan, J. Snell, J.S. Colton, A. Cummins, D.L. Gilbert, Protection from oxidation enhances the survival of cultured mesencephalic neurons, Exper. Neurol. 132 (1995) 54-61.
47. C.P. Connern, A.P. Halestrap, Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel, Biochem J. 302 (1994) 321-324.
48. B. Connor, M. Dragunow, The role of neuronal growth factors in neurodegenerative disorders of the human brain, Brain Res. Reviews 27 (1998) 1-39.
49. P. Constantini, V. Petronilli, R. Colonna, P. Bernardi, On the effects of paraquat on isolated mitochondria. Evidence that paraquat causes opening of the CsA-sensitive permeability transition pore synergistically with nitric oxide, Toxicol. 99 (1995) 77-88.
50. P. Constantini, B.V. Chernyak, V. Petronilli, P. Bernardi, Selective inhibition of the mitochondrial permeability transition pore at oxidation-reduction sensitive dithiol by monobromobimane, FEBS Lett 362 (1995) 239-242.
51. M. Corral-Debrinski, T. Horton, M.T. Lott, J.M. Schoffner, M.F. Beal, D.C. Wallace, Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age, Nature Genetics 2 (1992) 324-329.
52. G. Cortopassi, D. Shibata, N.W. Soong, N. Arnheim, A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues, Proc. Natl. Acad. Sci. USA 89 (1992) 7370-7374.
53. G. Cortopassi, E. Wang, Modeling the effects of age-related mtDNA mutation accumulation; Complex I deficiency, superoxide and cell death, Biochim. Biophys. Acta 1271 (1995) 171-176.
54. D. Crawford, I. Zbinden, P. Amstad, P. Cerutti, Oxidant stress induces the proto-oncogenes c-fos and c-myc in mouse epidermal cells, Oncogene 3 (1988) 27-32.
55. P. Damier, E.C. Hirsch, P. Zhang, Y. Agid, F. Javoy-Agid, Glutathione peroxidase, glial cells, and Parkinson's disease, Neuroscience 52 (1993) 1-6.
56. K.C. Das, Y. Lewis-Molock, C.W. White, Activation of NF-kappa B and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells, Am. J. Physiol. 269 (1995) L588-L602.
57. J.N. Davis, E.J. Hunnicutt Jr., J.C. Chisholm, A mitochondrial bottleneck hypothesis of Alzheimer's disease, Mol. Med. Today 1 (1995) 240-247.
58. J.N. Davis, W.D. Parker Jr., Evidence that two reports of mtDNA cytochrome c oxidase 'mutations' in Alzheimer's disease are based on nDNA pseudogenes of recent evolutionary origin, Biochem. Biophys. Res. Commun. 244 (1998) 877-883.
59. D.T. Dexter, C.J. Carter, F.R. Wells, F. Javoy-Agrid, Y. Agrid, A. Lees, P. Jenner, C.D. Marsden, Basal lipid peroxidation is increased in Parkinson's disease, J. Neurochem. 52 (1989) 381-389.
60. S. DiMauro, E. Bonilla, C.P. Lee, D.L. Schotland, A. Scarpa, H. Conn Jr., B. Chance, Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case, J. Neurol. Sci. 27 (1976) 217-232.
61. S. DiMauro, Mitochondrial myopathy, in: Feldman (Ed.), Current diagnosis in neurology, Mosby-Yearbook, St. Louis, 1994, pp. 340-345.
62. B. Dipasquale, A.M. Marini, R.J. Youle, Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons, Biochem. and Biophys. Res. Comm. 181 (1991) 1442-1448.
63. Y. Du, R.C. Dodel, K.R. Bales, R. Jemmerson, E. Hamilton-Byrd, S.M. Paul, Involvement of caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons, J. Neurochem. 69 (1997) 1382-1388.
64. +: implications for neurodegeneration, J. Neurochem 37 (1994) 584-591.
65. J.A. Dykens, Mitochondrial free radical production and oxidative pathophysiology: implications for neurodegenerative disease, in: M.F. Beal, N. Howell (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, Wiley-Liss, New York, 1997, pp. 29-55.
66. T. Dyrks, E. Dyrks, C.L. Master, K. Beyreuther, Amyloidogenicity of rodent and human beta A4 sequences, FEBS Lett. 324 (1993) 231-236.
67. T. Dyrks, E. Dyrks, C.L. Master, K. Beyreuther, Membrane inserted APP fragments containing the beta A4 sequence of Alzheimer's disease do not aggregate, FEBS Lett. 309 (1992) 20-24.
68. H.M. Ellerby, S.J. Martin, L.M. Ellerby, S.S. Naiem, S. Rabizadeh, G.S. Salvesen, C.A. Casiano, N.R. Cashman, D.R. Green, D. Bredesen, Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases, J. Neurosci. 17 (1997) 6165-6178.
69. + Induced apoptosis is potentiated by cyclosporin A and inhibited by aristolocic acid, Brain Res., in press.
70. B.A. Faucheux, J.J. Hauw, Y. Agid, E.C. Hirsch, The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease, Brain Res. 749 (1997) 17-170.
71. A. Favit, F. Nicoletti U., U. Scapagnini, P.L. Canonico, Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration, J. Cereb. Blood Flow Metab. 12 (1992) 638-645.
72. I. Fridovich, Superoxide radical and superoxide dismutases, Ann. Rev. of Biochem. 64 (1995) 97-112.
73. K. Furuke, T. Sasada, Y. Ueda-Taniguchi, A. Yamauchi, T. Inamoto, Y. Yamaoka, H. Masutani, J. Yodoi, Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type I-infected lymphocytes by 13-cis-retinoic acid, Cancer Research 57 (1997) 4916-4923.
74. A. Furuta, D.L. Price, C.A. Pardo, J.C. Troncoso, Z.S. Xu, N. Taniguchi, L.J. Martin, Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus, Am. J. Pathol. 146 (1995) 357-367.
75. D. Gabuzda, J. Busciglio, L.B. Chen, P. Matsudiara, B. Yanker, Inhibition of energy metabolism alters the processing of the amyloid precursor protein and induces a potentially amyloidogenic derivative, J. Biol. Chem. 269 (1994) 13623-13628.
76. C. Garcia-Ruiz, A. Colell, A. Morales, N. Kaplowitz, J.C. Fernandez-Checa, Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcriptional factor nuclear factor-κB: studies with isolated mitochondria and rat hepatocytes, Mol. Pharm. 48 (1995) 825-834.
77. J. Garthwaite, C.L. Boulton, Nitric oxide signaling in the central nervous system, Ann. Rev. Physiol. 57 (1995) 683-706.
78. D.C. Graham, Oxidative pathology for catecholamines in the genesis of neurolmelanin and cytotoxic quinones, Mol. Pharmacol. 14 (1978) 633-648.
79. L.J. Greenlund, T.L. Deckwerth, E.M. Johnson, Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed cell death, Neuron 14 (1995) 303-315.
80. W. Gsell, R. Conrad, M. Hickethier, E. Sofic, L. Frolich, I. Wichart, K. Jellinger, G. Moll, G. Ransmayr, J.S. Beckmann, P. Riederer, Decreased Catalase Activity but Unchanged SOD Activity in the brains of patients with dementia of Alzheimer's type, J. Neurochem. 64 (1995) 1216-1223.
81. M.E. Gurney, F.B. Cutting, P. Zhai, A. Doble, C.P. Taylor, P.K. Andrus, E.D. Hall, Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis, Annals Neurol. 39 (1996) 147-157.
82. T.M. Hagen, D.L. Yowe, J.C. Bartholomew, C.M. Wehr, K.L.M. Do, J.-Y. Park, B.A. Ames, Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase, Proc. Natl. Acad. Sci. USA 94 (1997) 3064-3069.
83. E.D. Hall, P.K. Andrus, J.A. Oostveen, J.S. Althaus, P.P. Von-Voigtlander, Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons, Brain Res. 742 (1996) 80-88.
84. B. Halliwell, J.M.C. Gutteridge (Eds.), Free Radicals in biology and medicine, edn. 2, Clarendon Press, Oxford, 1989.
85. D. Harman, Aging: a theory based on free radical and radiation chemistry, J. Gerontol. 11 (1956) 289-300.
86. D. Harman, Aging and disease: extending functional life span, Annals New York Acad. Sci. 786 (1996) 321-326.
87. D. Harman, A hypothesis on the pathogenesis of Alzheimer's disease, Annals New York Acad. Sci. 786 (1996) 152-168.
88. A. Hirano, Cytopathology in amyotrophic lateral sclerosis, Advances Neurol. 56 (1991) 91-101.
89. Y.S. Ho, A.J. Howard, J.D. Crapo, Molecular structure of a functional rat gene for manganese-containing superoxide dismutase, Am. J. Respir. Cell and Molec. Biol. 4 (1991) 278-286.
90. I.J. Holt, A.E. Harding, J.A. Morgan-Hughes, Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies, Nature 331 (1988) 717-719.
91. J.V. Hunter, S.P. Wolff, Oxidative glycation and free radical production: a causal mechanism of diabetic complications, Free Radie. Res. Commun. 12-13 (1991) 115-123, Pt 1.
92. C.A. Hutchinson, J.E. Newbold, S.S. Potter, M.H. Edgell, Maternal inheritance of mammalian mitochondrial DNA, Nature 251 (1974) 536-538.
93. C. Iadecola, D.A. Pelligrino, M.A. Moskowitz, N.A. Lassen, Nitric oxide synthase inhibition and cerebrovascular regulation, J. Cereb. Blood Flow Metab. 14 (1994) 175-192.
94. S. Ikebe, M. Tanaka, K. Ohno, W. Sato, K. Hattori, T. Kondo, Y. Mizuno, T. Ozawa, Increase of deleted mitochondrial DNA in the striatum of Parkinson's disease and senescence, Biochem. Biophys. Res. Commun. 170 (1990) 1044-1048.
95. S. Ikebe, M. Tanaka, T. Ozawa, Point mutations of mitochondrial genome in Parkinson's disease, Mol. Brain Res. 28 (1995) 281-295.
96. P.G. Ince, P.J. Shaw, J.M. Candy, D. Mantle, L. Tandon, W.D. Ehmann, W.R. Markesberry, Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease, Neurosci. Lett. 182 (1994) 87-90.
97. H. Ischiropoulos, L. Zhu, J. Chen, M. Tsai, J.C. Martin, C.D. Smith, J.S. Beckman, Peroxynitrite-mediated tyrosine nitration catalyzed by SOD, Arch. Biochem. Biophys 298 (1992) 431-437.
98. Y. Iwasaki, K. Ikeda, M. Kinoshita, Decreased cerebrospinal-fluid superoxide dismutase in amyotrophic lateral sclerosis, Lancet 342 (1993) 1118.
99. G.R. Jackson, D. Sampath, K. Werrbach-Perez, J.R. Perez-Polo, Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen-peroxidase-resistant pheochromocytoma subclone, Brain Res. 634 (1994) 69-76.
100. A. Jain, J. Martensson, E. Stole, P.A. Auld, A. Meister, Glutathione deficiency leads to mitochondrial damage in brain, Proc. Natl. Acad. Sci. USA 88 (1991) 1913-1917.
101. J.P. Jenuth, A.C. Peterson, E.A. Shoubridge, Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice, Nat. Genetics 16 (1997) 93-95.
102. L. Jornot, A. Junod, Differential regulation of glutathione peroxidase by selenomethionine and hyperoxia in endothelial cells, Biochem. J. 306 (1995) 581-587.
103. J. Kalra, A.H. Rajput, S.V. Mantha, K. Prasad, Serum antioxidant activity in Parkinson's disease, Mol. and Cell. Biochem. 110 (1992) 165-168.
104. N.G. Kennaway, R.D. Carrero-Valenzuela, G. Ewart, V.K. Balan, R. Lightowlers, Y.Z. Zhang, B.R. Powell, R.A. Capaldi, N.R. Buis, Isoforms of mammalian cytochrome c oxidase: correlation with human cytochrome c oxidase deficiency, Pediatr. Res. 28 (1990) 529-535.
105. A.A. Khan, M.J. Soloski, A.H. Sharp, G. Schilling, D.M. Sabatini, S.H. Li, C.A. Ross, S.H. Snyder, Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-triphosphate receptor, Science 273 (1996) 503-507.
106. A.W. Kilness, F.H. Hochberg, Amyotrophic lateral sclerosis in a high selenium environment, JAMA 237 (1977) 2843-2844.
107. S.J. Kish, C. Morito, O. Hornykiewicz, Glutathione peroxidase activity in Parkinson's disease brain, Neurosci. Lett. 58 (1985) 343-346.
108. S.J. Kish, C. Bergeron, A. Rajput, S. Dozic, F. Mastrogiacomo, L.-J. Chang, J. Wilson, L. DiStefano, J. Nobrega, Brain cytochrome oxidase in Alzheimer's disease, J. Neurochem. 59 (1992) 776-779.
109. K. Kitani, S. Kanai, M.C. Carillo, G.O. Ivy, Deprenyl increases the life span as well as activities of superoxide dismutase and catalase but not of glutathione peroxidase in selective brain regions in Fischer rats, Annals New York Acad. Sci. 717 (1994) 60-71.
110. R.M. Kluck, E. Bossy-Wetzel, D.R. Green, D.D. Newmeyer, The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis, Science 275 (1997) 1132-1136.
111. K.A. Koehler, J. Hines, E.G. Mansour, Y.M. Rustum, D.V. Jahagirdar, M.K. Jain, Comparison of the membrane-related effects of cytarabine and other agents on model membranes, Biochem. Pharm. 34 (1985) 4025-4031.
112. T. Kondo, Parkinson's disease and free radicals, mechanisms of neurodegeneration and neuroprotection, Annals New York Acad. Sci. 786 (1996) 206-216.
113. X.J. Kong, S.L. Lee, J.J. Lanzillo, B.L. Fanburg, CuZn superoxide dismutase in vascular cells: changes during cell cycling and exposure to hyperoxia, Am. J. Physiol. 264 (1993) L365-L367.
114. J. Kong, X. Zuoshang, Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1, J. Neurosci. 18 (1998) 3241-3250.
115. 2+-induced mitochondrial membrane permeabilization: role of coenzyme Q redox state, Am. J. Physiol. 269 (1995) C141-C147.
116. 2+ is dependent on mitochondrial-generated reactive oxygen species, FEBS Letts. 378 (1996) 150-152.
117. B.S. Kristal, B.P. Yu, An emerging hypothesis: synergistic induction of aging by free radicals and Maillard reactions, J. Gerontol. 47 (1992) B107-B114.
118. B.S. Kristal, J.M. Dubinsky, Mitochondrial permeability transition in the central nervous system: induction by calcium cycling-dependent and -independent pathways, J. Neurochem. 69 (1997) 524-538.
119. J.W. Langston, P. Ballard, J.W. Tetrud, I. Irwin, Chronic parkinsonism in humans due to a product of meperidine-analog synthesis, Science 219 (1983) 979-980.
120. A.L. Lehninger, A. Vercesi, E.A. Babaunmi, Regulation of calcium release from mitochondria by the oxidation-reduction state of pyridine nucleotides, Proc. Natl. Acad. Sci. USA 75 (1978) 1690-1694.
121. D. Leigh, Subacute necrotizing encephalomyelopathy in an infant, J. Neurol. Neurosurg. Psychiat. 14 (1951) 216-221.
122. D. Le-Quoc, K. Le-Quoc, Relationships between the NAD(P) redox state, fatty acid oxidation, and inner membrane permeability in rat liver mitochondria, Arch. Biochem. Biophys. 273 (1989) 466-478.
123. E. Levy-Lahad, T.D. Bird, Genetic factors in Alzheimer's disease: a review of recent advances, Annals Neurol. 40 (1996) 829-840.
124. G. Li, Y. Chen, J.T. Saari, Y.J. Kang, Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury, Am. J. Physiol. 273 (1997) H1090-H1095.
125. X. Liu, C.N. Kim, J. Yang, R. Jemmerson, X. Wang, Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c, Cell 86 (1996) 147-157.
126. S. Loprasert, P. Vattanaviboon, W. Praituan, S. Chamnongpol, S. Mongkolsuk, Regulation of the oxidative stress protective enzymes, catalase and superoxide dismutase in Xanthomonas - a review, Gene 179 (1996) 33-37.
127. M.A. Lovell, W.D. Ehmann, S.M. Butler, W.R. Markesbery, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease, Neurology 45 (1995) 1594-1601.
128. R. Luft, D. Ikkos, G. Palmieri, L. Ernster, B. Afzelius, A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical and morphological study, J. Clin. Invest. 41 (1962) 1776-1804.
129. R. Luft, Historical overview of Mitochondrial diseases, in: M.F. Beal, N. Howell (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, Wiley-Liss, New York, 1997, pp. 3-14.
130. M. Maeda, H. Takagi, H. Hattori, T. Matsuzaki, Localization of manganese superoxide dismutase in the cerebral cortex and hippocampus of Alzheimer-type senile dementia, Osaka City Med. J. 43 (1997) 1-5.
131. V.M. Mann, J.M. Cooper, D. Kriige, S.E. Daniel, A.H.V. Schapira, D. Marsden, Brain, skeletal muscle, and platelet homogenate mitochondrial functions in Parkinson's disease, Brain 115 (1992) 333-342.
132. P. Marchetti, M. Castedo, N. Zamzani, T. Hirsch, A. Haeffner, M. Geuskens, G. Kroemer, Mitochondrial permeability transition is a central coordinating event of apoptosis, J. Exp. Med. 184 (1996) 1155-1160.
133. P. Marchetti, S.A. Susin, D. Decaudin, S. Gamen, M. Castedo, T. Hirsch, N. Zamzani, J. Naval, A. Senik, G. Kroemer, Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA, Cancer Res. 56 (1996) 2033-2038.
134. W.R. Markesberry, Oxidative stress hypothesis in Alzheimer's disease, Free Rad. Bio. Med. 23 (1997) 134-147.
135. S.L. Marklund, N.G. Westman, E. Lundgren, G. Roos, Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues, Cancer. Res. 42 (1982) 1955-1961.
136. E. Martignoni, G. Bono, F. Blandini, E. Sinforiani, P. Merlo, G. Nappi, Monoamines and related metabolite levels in the CSF of patients with dementia of Alzheimer's type. Influence of treatment with L-deprenyl, J. Neural. Transm. Parkin. Dis. Dement. Sect. 3 (1991) 15-25.
137. R.J. Martilla, M. Roytta, H. Lorentz, U.K. Rinne, Oxygen toxicity protecting enzymes in the human brain, J. Neural. Trans. 74 (1988) 87-95.
138. P. Mecocci, U. MacGarvey, A.E. Kaufman, D. Koontz, J.M. Shoffner, D.C. Wallace, M.F. Beal, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease, Annals Neurol. 36 (1994) 747-751.
139. J.-L. Mendoza-Ramirez, L. Beltran-Parrazal, L. Verdugo-Diaz, C. Morgado-Valle, R. Drucker-Colin, Delay in manifestations of aging by grafting NGF cultured chromaffin cells in adulthood, Neurobiol. Aging 16 (1995) 907-916.
140. J. Mierau, F.J. Schneider, H.A. Ensinger, C.L. Chio, M.E. Lajiness, R.M. Huff, Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors, Eur. J. Pharmacol. 290 (1995) 29-36.
141. H. Mitsumoto, K. Ikeda, B. Klinkosz et al., Arrest of motor neuron disease in wobbler mice treated with CNTF and BDNF, Science 265 (1994) 1107-1110.
142. Y. Mizuno, K. Ohta, Regional distribution of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains, J. Neurochem. 46 (1986) 1344-1352.
143. Y. Mizuno, S. Ohta, M. Tanaka, S. Takamiya, K. Suzuki, T. Sato, H. Oya, T. Ozawa, Y. Kagawa, Deficiencies of the respiratory chain in Parkinson's disease, Biochem. Biophys. Res. Comm. 163 (1989) 1450-1455.
144. + in ventral mesencephalic-striatal coculture in rat, Neurosci. Lett. 170 (1994) 191-194.
145. E.B. Montgomery Jr., Heavy metals and the etiology of Parkinson's disease and other movement disorders, Toxicol. 97 (1995) 3-9.
146. E.M. Mutisya, A.C. Bowling, M.F. Beal, Cortical cytochrome oxidase activity is reduced in Alzheimer's disease, J. Neurochem. 63 (1994) 2179-2184.
147. C. Mytilineau, P. Werner, S. Molinari, A. DiRocco, G. Cohen, M.D. Yahr, Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease, J. Neural Transm.-Park. Dis. Dement Sect. 8 (1994) 223-228.
148. Y. Nakano, K. Hirayama, K. Terao, Hepatic ultrastructural changes and liver dysfunction in Amyotrophic lateral sclerosis, Arch. Neurol. 44 (1997) 103-106.
149. S. Nass, M.M. Nass, Intramitochondrial fibers and DNA characteristics: II. Enzymatic and other hydrolytic treatments, J. Cell Biol. 19 (1963) 613-629.
150. W. Nazareth, N. Yafei, M. Crompton, Inhibition of anoxia-induced injury in heart myocytes by cyclosporin A, J. Mol. and Cell. Cardiol. 23 (1991) 1351-1354.
151. +, a metabolite of the neurotoxin, MPTP, Life Sci. 36 (1985) 2503-2508.
152. 2+ and cell death, Annals New York Acad. Sci. 648 (1992) 17-27.
153. A.-L. Nieminen, A.K. Saylor, S.A. Tesfai, B. Herman, J.J. Lemasters, Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide, Biochem. J. 307 (1995) 99-106.
154. A.-L. Nieminen, T.G. Petrie, J.J. Lemasters, W.R. Selman, Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: evidence of the mitochondrial permeability transition, Neurosci. 75 (1996) 993-997.
155. G. Nistico, M.R. Ciriolo, K. Fiskin, M. Iannone, A. De Martino, G. Rotilio, NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats, Free Rad. Bio. Med. 12 (1992) 177-181.
156. K. Nishiyama, CuZn-SOD-like immunoreactivity is present in Lewy body inclusions from Parkinson's disease, Acta Neuropath. 89 (1995) 471-474.
157. S.A. Novgorodov, T.I. Gudz, Y.M. Milgrom, G.P. Brierly, The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporin A, J. Biol. Chem. 267 (1992) 16274-16282.
158. S.A. Novgorodov, T.I. Gudz, Permeability transition pore of the inner mitochondrial membrane can operate in two open states with different selectivities, J. Bioenerg. Biomemb. 28 (1996) 139-146.
159. T. Okabe, K. Hamaguchi, T. Inafuka, M. Hara, Aging and superoxide dismutase in cerebrospinal fluid, J. Neurol. Sci. 141 (1997) 100-104.
160. S.A. O'Reilly, J. Roedica, R.A. Hallewell, K. Alderson, S.L. Marklund, J. Kuby, P.D. Kushner, Motor neuron-astrocyte interactions in sporadic amyotrophic lateral sclerosis, Exper. Neurol. 131 (1995) 203-210.
161. G. Otero, M.A. Avila, D. Emfietzoglou, L.B. Clerch, D. Massaro, V. Notario, Increased Mn SOD activity, protein, and mRNA levels and concurrent induction of tumor necrosis factor α in radiation-initiated Syrian hamster cells, Molec. Carcin. 17 (1996) 175-180.
162. T. Ozawa, M. Tanaka, K. Ohno, W. Sato, K. Hattori, T. Kondo, Y. Mizuno, Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis, Biochem. Biophys. Res. Commun. 172 (1990) 483-489.
163. L. Packer, H.J. Tritschler, K. Wessel, Neuroprotection by the metabolic antioxidant α-lipoic acid, Free Rad. Biol. and Med. 22 (1997) 359-378.
164. + and nitric oxide simultaneously causes CsA-sensitive mitochondrial calcium efflux and depolarization, Biochem. Pharmacol. 51 (1996) 267-273.
165. M.A. Pappolla, R.A. Omar, K.S. Kim, N.K. Robakis, Immunohistochemical evidence of antioxidant stress in Alzheimer's disease, Am. J. Pathol. 140 (1992) 621-628.
166. W.D. Parker Jr., C.A. Oley, J.K. Parks, A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy, New Eng. J. Med. 320 (1989) 1331-1333.
167. W.D. Parker Jr., Sporadic neurologic disease and the electron transport chain: a hypothesis, in Pascuzzi (Ed.), Proceedings of the 1989 scientific meeting of the American Society for Neurological Investigation: new developments in neuromuscular disease, Bloomington: Indiana University Printing Services, 1990 (1989) pp. 59-64.
168. W.D. Parker Jr., S.J. Boyson, J.K. Parks, Abnormalities of the electron transport chain in idiopathic Parkinson's disease, Annals Neurol. 26 (1989) 719-723.
169. W.D. Parker, C.M. Filley, J.K. Parks, Cytochrome oxidase deficiency in Alzheimer's disease, Neurology 40 (1990) 1302-1303.
170. W.D. Parker, N.J. Mahr, C.M. Filley, J.K. Parks, M.A. Hughes, D.A. Young, C.M. Cullum, Reduced platelet cytochrome c oxidase activity in Alzheimer's disease, Neurology 44 (1994) 1086-1090.
171. W.D. Parker, J.K. Parks, C.M. Filley, B.K. Kleinschmidt-DeMasters, Electron transport defects in Alzheimer's disease brain, Neurology 44 (1994) 1090-1096.
172. + and beta amyloid peptide, Soc. Neurosci. Abst. 23 (1997) 740.1.
173. R.S. Partridge, S.M. Monroe, J.K. Parks, K. Johnson, W.D. Parker Jr., G.R. Eaton, S.S. Eaton, Spin trapping of azidyl and hydroxyl radicals in azide-inhibited submitochondrial particles, Arch. Biochem. Biophys. 310 (1994) 210-217.
174. J.G. Pastorino, J.W. Snyder, A. Serroni, J.B. Hoek, J.L. Farber, Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition, J. Biol. Chem. 268 (1993) 13791-13798.
175. J.G. Pastorino, G. Simbula, E. Gilfor, J.B. Hoek, J.L. Farber, Protoporphyrin IX, an endogenous ligand of the peripheral benzodiazepine receptor, potentiates induction of the mitochondrial permeability transition and the killing of cultured hepatocytes by rotenone, J. Biol. Chem. 49 (1994) 31041-31046.
176. 2+ depletion prevents anoxic death of hepatocytes by inhibiting mitochondrial permeability transition, Am. J. Pysiol. 268 (1995) C676-C685.
177. P.A. Pechan, K. Chowdhury, W. Seifert, Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture, NeuroReport 3 (1992) 469-472.
178. R. Perrins, S. Briancon, C. Jeandel, Y. Artur, A. Minn, F. Penin, G. Siest, Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase, and catalase in Alzheimer's disease: a case-control study, Gerontology 36 (1990) 306-313.
179. T.L. Perry, D.V. Godin, S. Hansen, Parkinson's disease: a disorder due to nigral glutathione deficiency?, Neurosci. Lett. 33 (1982) 305-310.
180. V. Petronilli, P. Constantini, L. Scorrano, R. Colonna, S. Passamonti, P. Bernardi, The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols, J. Biol. Chem. 24 (1994) 16638-16642.
181. D.R. Pfeiffer, T.I. Gudz, S.A. Novgorodov, W.L. Erdahl, The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition, J. Biol. Chem. 270 (1995) 4923-4932.
182. M.F. Piercey, W.E. Hoffmann, M.W. Smith, D.K. Hyslop, Inhibition of dopamine neuron firing by pramipexole, a D3-preferring dopamine agonist: comparison to other dopamine agonists, Eur. J. Pharmacol. 312 (1996) 35-44.
183. M.F. Piercey, D.K. Hyslop, W.E. Hoffmann, Excitation of type II anterior caudate neurons by stimulation of D3 receptors, Brain Res. 762 (1997) 19-28.
184. J. Poirier, A. Barbeau, Erythrocyte antioxidant activity in human patients with Parkinson's disease, Neurosci. Lett. 75 (1987) 345-348.
185. J. Poirier, D. Dea, A. Baccichet, C. Thiffault, Superoxide dismutase expression in Parkinson's disease, Annals New York Acad. Sci. 738 (1994) 116-120.
186. J. Poirier, C. Thifault, Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease?, Eur. Neurol. 33 (1993) 38-43.
187. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, B. Pike, H. Root, J. Rubenstein et al., Mutation in the α-Synuclein gene identified in families with Parkinson's disease, Science 276 (1997) 2045-2047.
188. W. Pryor, G.L. Squadrito, The chemistry of peroxynitrite, Am. J. Physiol. 268 (1995) L699-L722.
189. S. Przedborski, D.M. Donaldson, P.L. Murphy, O. Hirsch, D. Lange, A.B. Naini, D. McKenna-Yasek, R.H. Brown, Blood Superoxide dismutase, catalase, and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis, Neurodegeneration 5 (1996) 57-64.
190. S. Przedborski, V. Jackson-Lewis, R. Yokoyama, T. Shibata, V.L. Dawson, T.M. Dawson, Role of neuronal nitric oxide in MPTP-induced dopaminergic neurotoxicity, Proc. Natl. Acad. Sci. USA 93 (1996) 4565-4571.
191. R.J. Ragusa, C.K. Chow, J.D. Porter, Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy, Neuromuscular Disorders 7 (1997) 379-386.
192. G.N. Rao, B. Lassegue, K.K. Griendling, R.W. Alexander, Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid, Oncogene 8 (1993) 2759-2764.
193. D.J. Reed, M.K. Savage, Influence of metabolic inhibitors on mitochondrial permeability transition and glutathione status, Biochim. Biophys. Acta 1271 (1995) 43-50.
194. J.S. Richardson, Free radicals in the genesis of Alzheimer's disease, Annals New York Acad. Sci. 695 (1993) 73-76.
195. C. Richter, V. Gogvadze, R. Schlapbach, M. Schweizer, J. Schlegel, Nitric oxide kills hepatocytes by mobilizing mitochondrial calcium, Biochem. Biophys. Res. Commun. 205 (1994) 1143-1150.
196. P. Riederer, M. Strolin Benedetti, P. Dostert, E. Sofic, G. Heuschneider, C. Guffor, Do glutathione and ascorbic acid play a role in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine?, Pharmacol. Toxicol. 60 (1987) 39, Suppl. 1.
197. P. Riederer, E. Sofic, W.D. Rausch, B. Schmidt, G.P. Reynold, K. Jellinger, M.B.H. Youdim, Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains, J. Neurochem. 52 (1989) 515-520.
198. R.J. Reiter, R.C. Carneiro, C.S. Oh, Melatonin in relation to cellular antioxidant defense mechanisms, Hormone and Metab. Res. 29 (1997) 363-372.
199. D.R. Rosen, T. Siddique, D. Patterson et al., Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis, Nature 362 (1994) 59-62.
200. R. Rossen, H. Kabat, J.P. Anderson, Acute arrest of cerebral circulation in man, Arch. Neurol. Psychiatr. 50 (1943) 510-528.
201. Y. Sagara, R. Dargusch, E.G. Klier, D. Schubert, C. Behl, Increased antioxidant enzyme activity in amyloid protein-resistant cells, J. Neurosci. 16 (1996) 497-505.
202. H. Saggu, J. Cooksey, D. Dexter, F.R. Wells, A. Lees, P. Jenner, C.D. Marsden, A selective increase in particulate SOD activity in Parkinsonian substantia nigra, J. Neurochemistry 53 (1989) 692-697.
203. D. Sampath, G.R. Jackson, K. Werrbach-Perez, J.R. Perez-Polo, Effects of nerve growth factor on glutathione peroxidase and catalase in PC12 cells, J. Neurochem. 62 (1994) 2476-2479.
204. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider, L.J. Thal, A controlled study of selegeline, alpha-tocopherol, or both as treatment for Alzheimer's disease, N. Engl. J. Med. 336 (1997) 1216-1222.
205. A.H.V. Schapira, J.M. Cooper, D. Dexter, P. Jenner, J.B. Clark, C.D. Marsden, Mitochondrial complex I deficiency in Parkinson's disease, Lancet 1 (1989) 1269.
206. H.M. Schipper, Astrocytes, brain aging, and neurodegeneration, Neurobiol. of Aging 17 (1996) 467-480.
207. R. Schreck, P. Rieber, P.A. Baeuerle, Reactive oxygen species as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1, EMBO J. 10 (1991) 2247-2258.
208. J.B. Schulz, R.T. Matthews, M.M. Muqit, S.E. Brown, M.F. Beal, Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice, J. Neurochem. 64 (1995) 936-939.
209. J.B. Schulz, R.T. Matthews, D.R. Henshaw, M.F. Beal, Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases, Neuroscience 71 (1996) 1043-1048.
210. 2+ release from intact rat liver mitochondria, Biochemistry 35 (1996) 4524-4528.
211. J.P. Sheehan, R.H. Swerdlow, W.D. Parker Jr., S.W. Miller, R.E. Davis, J.B. Tuttle, Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease, J. Neurochem. 68 (1997) 1221-1233.
212. J.P. Sheehan, R.H. Swerdlow, S.W. Miller, R.E. Davis, W.D. Parker Jr., J.B. Tuttle, Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease, J. Neurosci. 17 (1997) 4612-4622.
213. J.G. Sheng, R.E. Mrak, W.S. Griffin, Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms, Acta Neuropathol. 94 (1997) 1-5.
214. M. Shibanuma, T. Kuroki, K. Nose, Induction of DNA replication and expression of proto-oncogene c-myc and c-fos in mouse epidermal cells, Oncogene 3 (1988) 17-22.
215. M.K. Shigenaga, T.M. Hagen, B.N. Ames, Oxidative damage and mitochondrial decay in aging, Proc. Natl. Acad. Sci. USA 91 (1994) 10771-10778.
216. E.A. Shoubridge, G. Karpati, E.M. Hastings, Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease, Cell 62 (1990) 43-49.
217. S. Simonetti, X. Chen, S. DiMauro, E. Schon, Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR, Biochim. Biophys. Acta 1180 (1992) 113-122.
218. N.A. Simonian, J.T. Coyle, Oxidative stress in neurodegenerative diseases, Ann. Rev. Pharm. Toxicol. 36 (1996) 83-106.
219. N.R. Sims, Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia, Metabolic Brain Disease 10 (1995) 191-217.
220. T.P. Singer, R.R. Ramsay, Mechanisms of the neurotoxicity of MPTP, FEBS Lett. 274 (1990) 1-8.
221. T.P. Singer, R.R. Ramsay, B.A.C., Deficiencies of NADPH and succinate dehydrogenase in degenerative diseases and myopathies, Biochim. Biophys. Acta 1271 (1995) 211-219.
222. M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.-D. Yan, D. Stern, L.M. Sayre, V.M. Monnie, G. Perry, Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc. Natl. Acad. Sci. USA 91 (1994) 5710-5714.
223. M.A. Smith, P.L. Richer-Harris, L.M. Sayre, J.S. Beckman, G. Perry, Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci. 17 (1997) 2653-2657.
224. M.A. Smith, L.M. Sayre, G. Perry, Morphological aspects of oxidative damage in Alzheimer's disease, in: M.F. Beal, N. Howell (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, Wiley-Liss, New York, 1997, pp. 335-342.
225. +-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase, NeuroReport 5 (1994) 2598-2600.
226. T.S. Smith, J.P. Bennett Jr., Mitochondrial toxins in neurodegenerative diseases: I. In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions, Brain Res. 765 (1997) 183-186.
227. +, Biochem. Pharm. 44 (1992) 833-835.
228. R.S. Sohal, A. Dubey, Mitochondrial oxidative damage, hydrogen peroxide release, and aging, Free Rad. Bio. Med. 16 (1994) 621-626.
229. R.S. Sohal, S. Agarwal, W.C. Orr, Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophilia, J. Biol. Chem. 270 (1995) 15671-15674.
230. P.M. Sokolove, K.W. Kinnally, A mitochondrial signal peptide from Neurospora crassa increases the permeability of isolated rat liver mitochondria, Arch. Biochem. and Biophys. 336 (1996) 69-76.
231. S.M. Somani, R. Ravi, L.P. Rybak, Effects of exercise training on antioxidant system in brain regions of rat, Pharm. Biochem. and Behav. 50 (1995) 635-639.
232. N.-W. Soong, D.R. Hinton, G. Cortopassi, N. Arnheim, Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain, Nature Genetics 2 (1992) 318-323.
233. + toxicity: involvement of the glutathione system, J. Neurochem. 59 (1992) 99-105.
234. H.M. Steinman, V.R. Naik, J.L. Abernethy, R.L. Hill, Bovine erythrocyte superoxide dismutase: complete amino acid sequence, J. Biol. Chem. 249 (1974) 7326-7338.
235. P. Stralin, S.L. Marklund, Effects of oxidative stress on expression of extracellular superoxide dismutase CuZn-Superoxide dismutase and Mn-superoxide dismutase, Biochem. J. 298 (1994) 347-352.
236. A. Suomalainen, A. Majander, M. Wallin, K. Setala, K. Kontula, H. Leinonen, T. Salmi, A. Paetau, M. Haltia, L. Valanne, J. Lonnqvist, L. Peltonen, H. Somer, Autosomal dominant progressive external opthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease, Annals Neurol. 48 (1997) 1244-1253.
237. Y.J. Suzuki, H.J. Forman, A. Sevanian, Oxidants as stimulators of signal transduction, Free Rad. Biol. and Med. 22 (1997) 269-285.
238. R.H. Swerdlow, J.K. Parks, S.W. Miller, J.B. Tuttle, P.A. Trimmer, J.P. Sheehan, J.P. Bennett Jr., R.E. Davis, W.D. Parker Jr., Origin and functional consequences of the complex I defect in Parkinson's disease, Annals Neurol. 40 (1996) 663-671.
239. R.H. Swerdlow, J.K. Parks, D.S. Cassarino, D.J. Maguire, R.S. Maguire, J.P. Bennett Jr., R.E. Davis, W.D. Parker Jr., Cybrids in Alzheimer's disease: a cellular model of the disease?, Neurology 49 (1997) 918-925.
240. R.H. Swerdlow, J.K. Parks, D.S. Cassarino, P.A. Trimmer, S.W. Miller, D.J. Maguire, J.P. Sheehan, R.S. Maguire, G. Pattee, V. Juel, L.H. Phillips, J.B. Tuttle, J.P. Bennett Jr., R.E. Davis, W.D. Parker Jr., Mitochondria in sporadic amyotrophic lateral sclerosis, Exper. Neurol., in press.
241. M.A. Symonyan, R.M. Nalbandyan, Interaction of hydrogen peroxide with superoxide dismutase from erythrocytes, FEBS Letts. 28 (1972) 22-24.
242. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells, Invest. Opthal. and Vis. Sci. 36 (1997) 1271-1279.
243. F. Tessier, H. Hida, A. Favier, P. Marconnet, Muscle GSH-Px activity after prolonged exercise, training, and selenium supplementation, Biol. Trace Elem. Res. 47 (1995) 279-285.
244. C. Thiffault, N. Aumont, R. Quirion, J. Poirier, Effect of MPTP and deprenyl on antioxidant enzymes and lipid peroxidation in mouse brain, J. Neurochem. 65 (1995) 2725-2733.
245. M. Tiedge, S. Lortz, J. Drinkgern, S. Lenzen, Relation between antioxidant enzyme gene expression and antioxidant defense status of insulin-producing cells, Diabetes 46 (1997) 1733-1742.
246. A.E. Tomikson, R.T. Bank, J. Kim, N. Bartfel, S. Linn, Mammalian mitochondrial endonuclease activities specific for ultraviolet-irradiated DNA, Nucleic Acids Res. 18 (1990) 929-935.
247. P.A. Trimmer, T.S. Smith, A.B. Jung, J.P. Bennett Jr., Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity, Neurodegeneration 5 (1996) 233-239.
248. L. Tsai, E.A. Sokoloski, The reaction of 4-hydroxy-2-nonenal with Nα-acetyl-L-histidine, Free Rad. Bio. Med. 19 (1995) 39-44.
249. S. Urano, Y. Asai, S. Makabe, M. Matsuo, N. Izumiyama, K. Ohtsubo, T. Endo, Oxidative injury of synapse and alteration of antioxidant defense systems in rats, and its prevention by vitamin E, Eur. J. Biochem. 245 (1997) 64-70.
250. K. Van Dyke, The possible role of peroxynitrite in Alzheimer's disease: a simple hypothesis that could be tested more thoroughly, Medical Hypotheses 48 (1997) 375-380.
251. M. Vincetti, D. Guidetti, M. Pinotti, S. Rovesti, M. Merlin, L. Vescovi, M. Bergomi, G. Vivoli, Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content, Epidemiology 7 (1996) 529-532.
252. D.C. Wallace, Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy, Science 242 (1988) 1427-1430.
253. D.C. Wallace, C. Stutgard, D. Murdock, T. Schurr, M.D. Brown, Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations, Proc. Natl. Acad. Sci. USA 94 (1997) 14900-14905.
254. D.C. Wallace, M.T. Lott, M.D. Brown, Mitochondrial defects in neurodegenerative diseases and aging, in: M.F. Beal, N. Howell (Eds.), Mitochondria and Free Radicals in Neurodegenerative Diseases, Wiley-Liss, New York, 1997, pp. 283-307.
255. E. Wang, G.A. Cortopassi, Mice with duplications and deletions at the Tme locus have altered MnSOD activity, J. Biol. Chem. 269 (1995) 22463-22465.
256. B. Warner, R. Papes, M. Heile, D. Spitz, J. Wispe, Expression of human Mn SOD in Chinese hamster ovary cells confers protection from oxidant injury, Am. J. Physiol. 264 (1993) L598-L605.
257. B.B. Warner, L. Stuart, S. Gebb, J.R. Wispe, Redox regulation of Mn SOD, Am. J. Physiol. 271 (1996) L150-L158.
258. Y.-A. Wei, S.-H. Kao, H.-C. Lee, Simultaneous increase of mitochondrial DNA deletions and lipid peroxidation in human aging, Annals New York Acad. Sci. 786 (1996) 24-43.
259. J.R. Wispe, J.C. Clark, M.S. Burhans, K.E. Kropp, T.R. Korfhagen, J.A. Whitsett, Synthesis and processing of the precursor for human mangano-superoxide dismutase, Biochim. Biophys. Acta 994 (1989) 30-36.
260. E.J. Wolvetang, K.L. Johnson, S.J. Ralph, A.W. Linnane, Mitochondrial respiratory chain inhibitors induce apoposis, FEBS Lett. 339 (1994) 40-44.
261. G.H. Wong, Protective roles of cytokines against radiation: induction of mitochondrial Mn SOD, Biochim. Biophys. Acta 1271 (1995) 205-209.
262. P.C. Wong, C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, N.A. Jenkins, S.S. Sisodia, D.W. Cleveland, D.L. Price, An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria, Neuron 14 (1995) 1105-1116.
263. G.F. Woolen, L.J. Currie, J.P. Bennett, M.B. Harrison, J.M. Trugman, W.D. Parker Jr., Maternal inheritance in Parkinson's disease, Annals Neurol. 41 (1997) 265-268.
264. E.Y. Wu, M.T. Smith, G. Bellomo, D. DiMonte, Relationships between mitochondrial transmembrane potential, ATP concentrations, and cytotoxicity in isolated rat hepatocytes, Arch. Biochem and Biophys. 282 (1990) 358-362.
265. + toxicity in nigral dopaminergic neurones, NeuroReport 7 (1996) 921-923.
266. N. Yamashita, S. Hoshida, M. Nishida, J. Igarashi, N. Taniguchi, M. Tada, T. Kuzuya, M. Hori, Heat shock-induced manganese superoxide dismutase enhances the tolerance of cardiac myocytes to hypoxia-reoxygenation injury, J. Molec. and Cell. Cardiol. 29 (1997) 1805-1813.
267. S.D. Yan, A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, Y.S. Zou, D. Pinsky, D. Stern, Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J. Biol. Chem. 269 (1994) 9889-9897.
268. M.B. Yim, J.H. Kang, H. Yim, H. Kwak, P.B. Chock, E.R. Stadtman, A gain of function of an amyotrophic lateral sclerosis-associated CuZn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide, Proc. Natl. Acad. Sci. USA 93 (1996) (1996) 5709-5714.
269. A. Yoritaka, N. Hattori, H. Mon, K. Kato, Y. Mizuno, An immunohistochemical study on manganese superoxide dismutase in Parkinson's disease, J. Neurol. Sci. 148 (1997) 181-186.
270. B.P. Yu, E.Z. Suescun, S.Y. Yang, Effect of age-related lipid peroxidation on membrane fluidity and phospholipase A2: modulation by dietary restriction, Mech. Ageing Dev. 72 (1992) 17-33.
271. B.P. Yu, J.J. Chen, C.M. Kang, M. Choe, Y.S. Maeng, B.S. Kristal, Mitochondrial aging and lipoperoxide products, Annals New York Acad. Sci. 786 (1996) 44-56.
272. E.C. Yuen, W.C. Mobley, Therapeutic potential of neurotrophic factors for neurological disorders, Annals Neurol. 40 (1996) 346-354.
273. N. Zamzani, S.A. Susin, P. Marchetti, T. Hirsch, I. Gomez-Monterrey, M. Casteda, G. Kroemer, Mitochondrial control of nuclear apoptosis, J. Exp. Med. 183 (1996) 1533-1544.
274. N. Zamzani, T. Hirsch, B. Dallaporta, P.X. Petit, G. Kroemer, Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis, J. Bioenerg. and Biomemb. 29 (1997) 185-193.
275. F.P. Zemlen, O.J. Thienhaus, H.B. Bosman, Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation, Brain Res. 476 (1989) 160-162.
276. M. Zoratti, I. Szabo, The mitochondrial permeability transition, Biochim. Biophys. Acta 1241 (1995) 139-176.